The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Angioedema (may cause UAO, asphyxia and death)
Publications
Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2019;28(5):e44-e45
Treatment of angiotensin receptor blocker-induced angioedema: A case series.
The Laryngoscope. 2015;125(7):1619-23
Side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: are we facing a new syndrome.
The American journal of cardiology. 2012;110(10):1552-3
[Angioedema due to losartan].
Medicina clinica. 2011;137(6):281-2
Losartan associated anaphylaxis and angioneurotic oedema.
JPMA. The Journal of the Pakistan Medical Association. 2010;60(8):685-6
Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.
Pharmacotherapy. 2002;22(9):1173-5
Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
The Laryngoscope. 2001;111(10):1729-31
Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
The Annals of pharmacotherapy. 2000;34(4):526-8
ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
The Annals of pharmacotherapy. 1998;32(10):1060-6
Angioedema induced by the angiotensin II blocker losartan.
The New England journal of medicine. 1995;333(23):1572